Quick Answer
SYNAPTICS Inc reported Cash and Equivalents of $391.50 million for fiscal year 2025.
SYNAPTICS Inc Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $391.50M | -55.4% |
| 2024 | $876.90M | -5.2% |
| 2023 | $924.70M | +12.2% |
| 2022 | $824.00M | -1.5% |
| 2021 | $836.30M | +9.5% |
| 2020 | $763.40M | +132.9% |
| 2019 | $327.80M | +8.9% |
| 2018 | $301.00M | -18.2% |
| 2017 | $367.80M | +4.4% |
| 2016 | $352.20M | -11.9% |
| 2015 | $399.90M | -10.6% |
| 2014 | $447.20M | +25.9% |
| 2013 | $355.30M | +16.5% |
| 2012 | $305.00M | +23.4% |
| 2011 | $247.15M | +17.8% |
| 2010 | $209.86M | +24.1% |
| 2009 | $169.04M | +75.7% |
| 2008 | $96.22M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $437.40M | -26.6% | -4.9% |
| September 30, 2025 | $459.90M | -46.1% | +17.5% |
| June 30, 2025 | $391.50M | -55.4% | +8.6% |
| March 31, 2025 | $360.40M | -56.5% | -39.5% |
| December 31, 2024 | $596.10M | -29.5% | -30.2% |
| September 30, 2024 | $853.60M | +6.5% | -2.7% |
| June 30, 2024 | $876.90M | -5.2% | +5.9% |
| March 31, 2024 | $828.10M | -7.8% | -2.1% |
- SYNAPTICS Inc showed a decrease of -55.4% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2008–2025 period, SYNAPTICS Inc’s cash and equivalents has grown by 306.9% (from $96.22 million to $391.50 million).
- The most recent figure is from SYNAPTICS Inc’s fiscal year 2025 report (Form 10-K), filed with the SEC on August 21, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: